| Business Name: |
Mirati Therapeutics |
| Contact Person: |
Charles Baum, Chief Executive Officer |
| Address: |
9363 Towne Center Drive, San Diego, California 92121 |
| Phone Number: |
(858) 332-3410 |
| Annual Revenue (USD): |
Unknown |
| Founding Year: |
1995 |
| Location Type: |
Headquarters |
| Employee Number: |
1 to 4 |
| Business Type: |
B2B & B2C |
| Business Category: |
|
| SIC Code: |
2834 |
| NAICS Code: |
8121990 |
| Share This Business: |
|
| Related Businesses: |
Tioga Pharmaceuticals Inc - San Diego, CA 92121
Amplyx Pharmaceuticals Inc - San Diego, CA 92121
Depotech Corp - San Diego, CA 92121
Pacira Pharmaceuticals Inc - San Diego, CA 92121
Amylin Ohio LLC - San Diego, CA 92121
Conatus Pharmaceuticals Inc - San Diego, CA 92121
Novomedix - San Diego, CA 92121
Coda Therapeutics Inc - San Diego, CA 92121
Bioserv Corp - San Diego, CA 92121
Proprius Inc - San Diego, CA 92121
Arena Pharmaceuticals Inc - San Diego, CA 92121
Amaze Therapeutics - San Diego, CA 92121
Formex LLC - San Diego, CA 92121
Prometheus Rxdx Inc - San Diego, CA 92121
Neuropore Therapies - San Diego, CA 92121
Regulus Therapeutics Inc - San Diego, CA 92121
Skyepharma Inc - San Diego, CA 92121
Phage Biotechnology Corporation - San Diego, CA 92121
Advanced Molecular Design Inc - San Diego, CA 92121
Epigen Biosciences Inc - San Diego, CA 92121
|
The company Mirati Therapeutics provides BOTH services in the form of from its headquarters in California.
1 to 4 employees work for Mirati Therapeutics, and the business now earns Unknown per annum.
Mirati Therapeutics was launched in 1995 and is classified under SIC code and category 2834 , and NAICS number and grouping 8121990 .
To contact Mirati Therapeutics, please call Charles Baum, Chief Executive Officer with the phone number (858) 332-3410 or visit its headquarters at 9363 Towne Center Drive in San Diego, California 92121.
The location of the headquarters can also be found using the coordinates 32.876902,-117.207507.
Read more details about this business on the webpage or follow the company’s social media accounts, on Twitter and on Facebook.